These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9727607)

  • 61. Hypertriglyceridemia is exacerbated by slow lipolysis of triacylglycerol-rich lipoproteins in fed but not fasted streptozotocin diabetic rats.
    Mamo JC; Hirano T; Sainsbury A; Fitzgerald AK; Redgrave TG
    Biochim Biophys Acta; 1992 Oct; 1128(2-3):132-8. PubMed ID: 1420285
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A novel apolipoprotein C-II mimetic peptide that activates lipoprotein lipase and decreases serum triglycerides in apolipoprotein E-knockout mice.
    Amar MJ; Sakurai T; Sakurai-Ikuta A; Sviridov D; Freeman L; Ahsan L; Remaley AT
    J Pharmacol Exp Ther; 2015 Feb; 352(2):227-35. PubMed ID: 25395590
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Lipid transfer between human plasma low-density lipoprotein and a triolein/phospholipid microemulsion catalyzed by insect hemolymph lipid transfer particle.
    Ando S; Ryan RO; Yokoyama S
    Biochim Biophys Acta; 1990 Apr; 1043(3):289-94. PubMed ID: 2108726
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Lipolytic degradation of human very low density lipoproteins by human milk lipoprotein lipase: the identification of lipoprotein B as the main lipoprotein degradation product.
    Alaupovic P; Wang CS; McConathy WJ; Weiser D; Downs D
    Arch Biochem Biophys; 1986 Jan; 244(1):226-37. PubMed ID: 3080947
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Reduced lipolysis of large apo E-poor very-low-density lipoprotein subfractions from type IV hypertriglyceridemic subjects in vitro and in vivo.
    Evans AJ; Wolfe BM; Strong WL; Huff MW
    Metabolism; 1993 Jan; 42(1):105-15. PubMed ID: 8446037
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Acute hypoxia induces hypertriglyceridemia by decreasing plasma triglyceride clearance in mice.
    Jun JC; Shin MK; Yao Q; Bevans-Fonti S; Poole J; Drager LF; Polotsky VY
    Am J Physiol Endocrinol Metab; 2012 Aug; 303(3):E377-88. PubMed ID: 22621867
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Improving the Physicochemical Stability of Soy Phospholipid-Stabilized Emulsions Loaded with Lutein by the Addition of Sphingomyelin and Cholesterol: Inspired by a Milk Fat Globule Membrane.
    Liang L; Liu Y; Zhu J; Wen C; Liu X; Zhang J; Li Y; Liu G; Xu X
    J Agric Food Chem; 2023 Oct; 71(41):15305-15318. PubMed ID: 37815121
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The incorporation and metabolism of amyloid-beta into chylomicron-like lipid emulsions.
    James AP; Pal S; Gennat HC; Vine DF; Mamo JC
    J Alzheimers Dis; 2003 Jun; 5(3):179-88. PubMed ID: 12897403
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Oleic acid allows more apoprotein A-1 to bind with higher affinity to large emulsion particles saturated with cholesterol.
    Derksen A; Ekman S; Small DM
    J Biol Chem; 1989 Apr; 264(12):6935-40. PubMed ID: 2496124
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A technique to estimate the apparent surface pressure of emulsion particles using apolipoproteins as probes.
    Small DH; Phillips M
    Adv Colloid Interface Sci; 1992 Sep; 41():1-8. PubMed ID: 1418772
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Carnitine supplementation and fat emulsion clearance and utilization.
    Lave T; Lutz O; Frey A; Ehret C; Bach AC
    Infusionstherapie; 1988 Aug; 15(4):152-7. PubMed ID: 3182097
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of different molecular species of phosphatidylcholine on the clearance of emulsion particle lipids.
    Robins SJ; Fasulo JM; Patton GM
    J Lipid Res; 1988 Sep; 29(9):1195-203. PubMed ID: 3183525
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Physical states of surface and core lipids in lipid emulsions and apolipoprotein binding to the emulsion surface.
    Saito H; Minamida T; Arimoto I; Handa T; Miyajima K
    J Biol Chem; 1996 Jun; 271(26):15515-20. PubMed ID: 8663047
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The effects of emulsifying agents on disposition of lipid-soluble drugs included in fat emulsion.
    Suzuki Y; Masumitsu Y; Okudaira K; Hayashi M
    Drug Metab Pharmacokinet; 2004 Feb; 19(1):62-7. PubMed ID: 15499171
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Milk sphingomyelin is more effective than egg sphingomyelin in inhibiting intestinal absorption of cholesterol and fat in rats.
    Noh SK; Koo SI
    J Nutr; 2004 Oct; 134(10):2611-6. PubMed ID: 15465755
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Plasma kinetics of a cholesterol-rich emulsion in subjects with or without coronary artery disease.
    Santos RD; Hueb W; Oliveira AA; Ramires JA; Maranhão RC
    J Lipid Res; 2003 Mar; 44(3):464-9. PubMed ID: 12562871
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Kinetic Modeling of
    Infantes-Garcia MR; Verkempinck SHE; Hendrickx ME; Grauwet T
    J Agric Food Chem; 2021 Apr; 69(16):4708-4719. PubMed ID: 33856215
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Metabolism of a lipid nanoemulsion resembling low-density lipoprotein in patients with grade iii obesity.
    Dantas SA; Ficker ES; Vinagre CG; Ianni BM; Maranhão RC; Mady C
    Clinics (Sao Paulo); 2010; 65(1):23-7. PubMed ID: 20126342
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Fat emulsions are more than energy suppliers.
    Carpentier YA; Bihain BE; Deckelbaum RJ
    Infusionsther Klin Ernahr; 1986 Aug; 13(4):182-4. PubMed ID: 3531009
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The metabolic distinctiveness of emulsified lipid particles in the bloodstream and its clinical implications.
    Iriyama K
    Surg Today; 1996; 26(9):673-8. PubMed ID: 8883236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.